| Trial ID: | L2147 |
| Source ID: | NCT03112382
|
| Associated Drug: |
Zinc Supplement Plus Vitamin A And E
|
| Title: |
Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
SLC30A8
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type II
|
| Interventions: |
DRUG: zinc supplement plus vitamin A and E|DRUG: vitamin A and E
|
| Outcome Measures: |
Primary: SLC30A8 rs13266634 polymorphism, genetic screening of SLC30A8 : solute carrier family 30 member 8, one year|serum zinc, at base line | Secondary: change from baseline in fasting and 2hr post prandial blood glucose at three months, at base line and after three months|change from baseline in HbA1c at three months, base line and three months|change from baseline in lipid profile at three months, lipid profile: total cholesterol, triglyceride, HDL, LDL., base line and three months|change from baseline in fasting serum insulin at three months, baseline and three months|change from baseline in ALT level at three months, baseline and three months|serum Mg, baseline|creatinine level, baseline|serum Iron, baseline|change from baseline in total serum Calcium at three months, baseline and three months
|
| Sponsor/Collaborators: |
Sponsor: Cairo University
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
80
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SCREENING
|
| Start Date: |
2015-11
|
| Completion Date: |
2017-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-08-08
|
| Locations: |
theoutpatient clinics, department of internal medicine, Cairo University teaching hospitals,, Cairo, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT03112382
|
